The quality-of-life impact of prostate cancer treatments.
Publication/Presentation Date
5-1-2010
Abstract
Many options exist for the treatment of localized prostate cancer. In the decision to choose a therapeutic option for localized disease, many variables need to be considered such as tumor characteristics, clinical stage, the patient's overall health and life expectancy, and preferences of both the physician and patient. Another important consideration is the health-related quality of life (HRQOL) implications of a given treatment option. The importance of HRQOL relative to the potential side effects of prostate cancer treatments has grown over the past few years. Although our collective awareness has increased, objective data on HRQOL for prostate cancer treatment are lacking due to a paucity of prospective clinical trial data. This review defines the concept of HRQOL, discusses what is currently known about the impact of various treatments on HRQOL, and summarizes the recent literature in this area relating to the management of localized prostate cancer.
Volume
11
Issue
3
First Page
139
Last Page
146
ISSN
1534-6285
Published In/Presented At
Singh, J., Trabulsi, E. J., & Gomella, L. G. (2010). The quality-of-life impact of prostate cancer treatments. Current urology reports, 11(3), 139–146. https://doi.org/10.1007/s11934-010-0103-y
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
20425619
Department(s)
Administration and Leadership
Document Type
Article